給 業 界 的 信   Brilinta (ticagrelor) - Assessing the Potential Risks of a Worsening of a Slow and Irregular Heartbeat (Bradyarrhythmia) and Partial or Complete Block in the Transmission of Heart Impulses (Second- and Third-Degree Atrioventricular Block) (Letter to Healthcare Professionals) (English only)       附件: Brilinta (ticagrelor) - Assessing the Potential Risks of a Worsening of a Slow and Irregular Heartbeat (Bradyarrhythmia) and Partial or Complete Block in the Transmission of Heart Impulses (Second- and Third-Degree Atrioventricular Block) (English only)   Related Information: Canada: Summary Safety Review: Brilinta (ticagrelor): Assessing the potential ri... 上載於 2020-07-07